Notice
- Important: This guidance is under active development by NHS England and content may be added or updated on a regular basis.
- This Implementation Guide is currently in Draft and SHOULD NOT be used for development or active implementation without express direction from the NHS England Genomics Unit.
Observation-GenomicTherapeuticImplication-Example
Example of an Observation representing a Therapeutic Implication derived from Genomic Testing.
Observation |
id : Observation-GenomicTherapeuticImplication-Example |
meta |
profile : http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/therapeutic-implication |
profile : http://hl7.eu/fhir/laboratory/StructureDefinition/Observation-resultslab-eu-lab |
status : final |
category |
coding |
system : http://terminology.hl7.org/CodeSystem/observation-category |
code : laboratory |
category |
coding |
system : http://terminology.hl7.org/CodeSystem/v2-0074 |
code : GE |
code |
coding |
system : http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs |
code : therapeutic-implication |
subject |
reference : Patient/Patient-PheobeSmitham-Example |
effective : 2023-09-16 |
performer |
identifier |
system : https://fhir.nhs.uk/Id/ods-organization-code |
value : R0A |
derivedFrom |
reference : Observation/Observation-GenomicsVariantSLC52A2-Example |
component |
code |
coding |
system : http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs |
code : therapeutic-implication |
display : Therapeutic Implication |
value |
coding |
system : http://loinc.org |
code : LA9661-5 |
display : Presumed responsive |
component |
code |
coding |
system : http://loinc.org |
code : 51963-7 |
display : Medication assessed |
value |
coding |
system : http://snomed.info/sct |
code : 438481000124108 |
display : Riboflavin supplement |
note |
text : High dose riboflavin supplementation has been reported to ameliorate the progression of this disorder (Foley et al 2014 PMID22740598) |
{
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/therapeutic-implication",
"http://hl7.eu/fhir/laboratory/StructureDefinition/Observation-resultslab-eu-lab"
]
},
{
]
},
{
}
],
{
}
]
},
},
],
],
{
{
}
]
},
]
}
},
{
},
{
}
]
}
}
],
{
"text": "High dose riboflavin supplementation has been reported to ameliorate the progression of this disorder (Foley et al 2014 PMID22740598)"
}
]
}
<profile value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/therapeutic-implication" />
</meta>
</coding>
</category>
</coding>
</category>
</coding>
</code>
</subject>
</identifier>
</performer>
<text value="High dose riboflavin supplementation has been reported to ameliorate the progression of this disorder (Foley et al 2014 PMID22740598)" />
</note>
</derivedFrom>
</coding>
</code>
</coding>
</valueCodeableConcept>
</component>
</coding>
</code>
</coding>
</valueCodeableConcept>
</component>
</Observation>